RB
ABBV icon

Renasant Bank’s AbbVie ABBV Stock Holding History

Renasant Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
6,332
+1,377
+28% +$296K 1.02% 29
2026
Q1 		$1.08M Buy
4,955
+2,914
+143% +$646K 0.76% 34
2025
Q4 		$466K Sell
2,041
-157
-7% -$35.8K 0.32% 88
2025
Q3 		$509K Sell
2,198
-24
-1% -$4.89K 0.32% 88
2025
Q2 		$412K Sell
2,222
-3,187
-59% -$592K 0.28% 98
2025
Q1 		$1.13M Sell
5,409
-1,919
-26% -$373K 0.75% 37
2024
Q4 		$1.3M Buy
7,328
+210
+3% +$38.6K 0.84% 34
2024
Q3 		$1.41M Sell
7,118
-658
-8% -$123K 0.92% 30
2024
Q2 		$1.33M Sell
7,776
-1,468
-16% -$243K 0.92% 36
2024
Q1 		$1.68M Sell
9,244
-906
-9% -$156K 1.2% 15
2023
Q4 		$1.57M Buy
10,150
+1,066
+12% +$155K 1.25% 12
2023
Q3 		$1.35M Buy
9,084
+1,014
+13% +$149K 1.14% 14
2023
Q2 		$1.09M Sell
8,070
-1,498
-16% -$220K 0.89% 29
2023
Q1 		$1.52M Sell
9,568
-495
-5% -$75.7K 1.18% 15
2022
Q4 		$1.63M Sell
10,063
-489
-5% -$75K 1.23% 13
2022
Q3 		$1.42M Buy
10,552
+1,435
+16% +$206K 1.25% 16
2022
Q2 		$1.4M Buy
9,117
+1,337
+17% +$204K 1.14% 17
2022
Q1 		$1.26M Buy
7,780
+1,761
+29% +$256K 0.85% 29
2021
Q4 		$815K Buy
6,019
+1,310
+28% +$155K 0.55% 47
2021
Q3 		$508K Sell
4,709
-411
-8% -$47K 0.4% 81
2021
Q2 		$576K Buy
5,120
+40
+0.8% +$4.5K 0.44% 74
2021
Q1 		$549K Sell
5,080
-729
-13% -$78K 0.44% 69
2020
Q4 		$622K Buy
+5,809
New +$558K 0.51% 55

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renasant Bank's ABBV Position: Q2 2026 in Review

Renasant Bank increased its AbbVie (ABBV) stake by 28% in Q2 2026, buying an estimated $296K and bringing the position to 6,332 shares worth $1.59M. The position accounts for 1.02% of the portfolio, ranked #29.

Renasant Bank first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.68M in Q1 2024. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Renasant Bank held 6,332 shares of AbbVie worth $1.59M as of Q2 2026.
  • Renasant Bank bought 1,377 AbbVie shares in Q2 2026, an estimated $296K.
  • AbbVie made up 1.02% of Renasant Bank's portfolio in Q2 2026, its #29 holding.
  • Renasant Bank first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Renasant Bank's AbbVie position peaked at $1.68M in Q1 2024.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Renasant Bank's 13F filing for Q2 2026, filed 11 Aug 2026.